India to Australia: Cephalexin Export Trade Route
India has recorded 195 verified shipments of Cephalexin exported to Australia, representing a combined trade value of $8.4M USD. This corridor is served by 7 active Indian exporters, with an average shipment value of $43.0K USD. The leading Indian exporter is SUN PHARMACEUTICAL INDUSTRIES LIMITED, which accounts for 75% of total export value with 145 shipments worth $6.3M USD. On the buying side, M/S. SUN PHARMA ANZ PTY LTD is the largest importer in Australia with $3.0M USD in purchases. The top 3 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SUN PHARMACEUTICAL INDUSTRIES LIMITED , LUPIN LIMITED — together control of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Australia Cephalexin corridor is one of India's established pharmaceutical export routes, with 195 shipments documented worth a combined $8.4M USD. The route is dominated by SUN PHARMACEUTICAL INDUSTRIES LIMITED, which alone accounts for roughly 75% of all export value, reflecting the consolidated nature of India's cephalexin manufacturing sector.
Across 7 active suppliers, the average shipment value stands at $43.0K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with cephalexin's non-urgent bulk-order profile.
Shipment activity peaks during April-June, with an average transit time of 14 days port-to-port. The route has recorded an annual growth rate of 5%, placing it at rank #5 among India's top cephalexin export destinations globally.
On the import side, key buyers of Indian cephalexin in Australia include M/S. SUN PHARMA ANZ PTY LTD, M S SUN PHARMA ANZ PTY LIMITED, M/S. SUN PHARMA ANZ PTY LTD and 11 others. M/S. SUN PHARMA ANZ PTY LTD is the single largest importer with 74 shipments valued at $3.0M USD.
